SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-236377
Filing Date
2024-10-11
Accepted
2024-10-11 06:15:59
Documents
14
Period of Report
2024-10-09
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d834511d8k.htm   iXBRL 8-K 37216
2 EX-99.1 d834511dex991.htm EX-99.1 18998
  Complete submission text file 0001193125-24-236377.txt   193083

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tsbx-20241009.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsbx-20241009_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsbx-20241009_pre.xml EX-101.PRE 11718
16 EXTRACTED XBRL INSTANCE DOCUMENT d834511d8k_htm.xml XML 3769
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41747 | Film No.: 241366354
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)